Advaxis To Develop Oral Formulation Of Live Listeria
Published: 20-May-2009
Advaxis, in collaboration with a healthcare company, Collaborator, has applied for a $2 million US bio-defense grant. The move is in response to request from Northeast Biodefense Centre to develop oral formulation of Advaxis’s Live Listeria Technology for the prevention of influenza.
Advaxis' bioengineered Listeria monocytogenes (Lm) carrier system will be used with Collaborator's influenza multi-antigen technology to produce oral vaccine against influenza.
Thomas A. Moore, CEO of Advaxis, said: “Although Advaxis had worked primarily in the development of cancer vaccines, our technology has potentially considerable use in infectious disease applications. Working in the biodefense arena opens up new opportunities for the Company's technology and it's commercialization.”
New Jersey-based Advaxis is also engaged in the development of proprietary Listeria monocytogenes (Lm) cancer vaccines, and attenuated live Lm vaccines that deliver engineered tumor antigens, which stimulate multiple simultaneous immunological mechanisms to fight cancer.
Delicious
Digg
Reddit
Stumble
Facebook
LinkedInNetwork Sites
Mail sent successfully
Suppliers To This Sector
Browse A-Z
Vetter Pharma International
High-Quality Aseptically Pre-Filled Injection Systems, Cartridges and Vials ...
Turku Region
A Bright Future in a Great Location ...
TNO
Pharma Services: From Discovery to the Clinic ...
Thomson Reuters
The World's Leading Source of Life Sciences Intelligent Information ...
Thermo Fisher Scientific
The world leader in serving science ...
Tecnosoft
Monitoring Systems for Temperature, Humidity and Pressure ...
White Papers
Browse A-Z
Water Treatment
From the control room to the downstream processing area and with an eye on utilities servi ...
A Vaccinne Bioassay Case Study – A Successful Strategic Outsourcing Model
Increasingly, pharma and biotech firms are searching for new drivers of revenue and profit ...
USB HotStart-IT for Real Time PCR
USB® Products from Affymetrix have a long-standing reputation in the life science marketpl ...
Enabling Drug Delivery Deal Making
Transdermal drug delivery: Time for a closer look. To find out more download this free whi ...
Automating Training Control Processes to Comply with FDA Requirements
Well-managed training programs minimize the risk of non-compliance and improve product qua ...
TNO Pharma Services: From Discovery to the Clinic
Our kinetics & metabolism experts can help you select and further develop your candidate d ...
